[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Report 2017

October 2017 | 100 pages | ID: A4ECD473CF0PEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Onychomycosis (Tinea Unguium) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Onychomycosis (Tinea Unguium) Drug for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Onychomycosis (Tinea Unguium) Drug market competition by top manufacturers/players, with Onychomycosis (Tinea Unguium) Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Johnson & Johnson
  • GSK
  • Novartis
  • Pfizer
  • Valeant Pharma
  • Kaken Pharmaceutical
  • Galderma
  • Xiuzheng Pharmaceutical
  • Letai
  • Qilu Pharmaceutical
On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
  • Oral Type
  • External Use Type
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Onychomycosis (Tinea Unguium) Drug for each application, includin
  • Age under 18
  • Age 18-50
  • Age above 50
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Report 2017

1 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG OVERVIEW

1.1 Product Overview and Scope of Onychomycosis (Tinea Unguium) Drug
1.2 Classification of Onychomycosis (Tinea Unguium) Drug by Product Category
  1.2.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Oral Type
  1.2.4 External Use Type
1.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market by Application/End Users
  1.3.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Age under
  1.3.3 Age 18-50
  1.3.4 Age above
1.4 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market by Region
  1.4.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Onychomycosis (Tinea Unguium) Drug (2012-2022)
  1.5.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug (Volume) by Application
2.4 Asia-Pacific Onychomycosis (Tinea Unguium) Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Region (2012-2017)

3 CHINA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Onychomycosis (Tinea Unguium) Drug Sales and Value (2012-2017)
  3.1.1 China Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2017)
  3.1.3 China Onychomycosis (Tinea Unguium) Drug Sales Price Trend (2012-2017)
3.2 China Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Type
3.3 China Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Application

4 JAPAN ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Onychomycosis (Tinea Unguium) Drug Sales and Value (2012-2017)
  4.1.1 Japan Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Onychomycosis (Tinea Unguium) Drug Sales Price Trend (2012-2017)
4.2 Japan Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Type
4.3 Japan Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Application

5 SOUTH KOREA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Onychomycosis (Tinea Unguium) Drug Sales and Value (2012-2017)
  5.1.1 South Korea Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Onychomycosis (Tinea Unguium) Drug Sales Price Trend (2012-2017)
5.2 South Korea Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Type
5.3 South Korea Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Application

6 TAIWAN ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Onychomycosis (Tinea Unguium) Drug Sales and Value (2012-2017)
  6.1.1 Taiwan Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Onychomycosis (Tinea Unguium) Drug Sales Price Trend (2012-2017)
6.2 Taiwan Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Type
6.3 Taiwan Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Application

7 INDIA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Onychomycosis (Tinea Unguium) Drug Sales and Value (2012-2017)
  7.1.1 India Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2017)
  7.1.3 India Onychomycosis (Tinea Unguium) Drug Sales Price Trend (2012-2017)
7.2 India Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Type
7.3 India Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales and Value (2012-2017)
  8.1.1 Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Application

9 AUSTRALIA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Onychomycosis (Tinea Unguium) Drug Sales and Value (2012-2017)
  9.1.1 Australia Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Onychomycosis (Tinea Unguium) Drug Sales Price Trend (2012-2017)
9.2 Australia Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Type
9.3 Australia Onychomycosis (Tinea Unguium) Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Johnson & Johnson
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 GSK
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Novartis
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Pfizer
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Valeant Pharma
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Kaken Pharmaceutical
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Galderma
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Xiuzheng Pharmaceutical
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Letai
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Qilu Pharmaceutical
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MANUFACTURING COST ANALYSIS

11.1 Onychomycosis (Tinea Unguium) Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Onychomycosis (Tinea Unguium) Drug
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Type (2012-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Type Product Picture
Figure External Use Type Product Picture
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales (K MT) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Application in 2016
Figure Age under 18 Examples
Table Key Downstream Customer in Age under
Figure Age 18-50 Examples
Table Key Downstream Customer in Age 18-50
Figure Age above 50 Examples
Table Key Downstream Customer in Age above
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size (Million USD) by Region (2012-2022)
Figure China Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) and Growth Rate (2012-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Major Players Product Sales Volume (K MT)(2012-2017)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales (K MT) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Share by Players
Figure 2017 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Share by Players
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Type (2012-2017)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Onychomycosis (Tinea Unguium) Drug by Type (2012-2017)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) and Market Share by Region (2012-2017)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Region (2012-2017)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2016
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Onychomycosis (Tinea Unguium) Drug by Region (2012-2017)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region in 2016
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) and Market Share by Application (2012-2017)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2012-2017)
Figure China Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure China Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Onychomycosis (Tinea Unguium) Drug Sales Price (USD/MT) Trend (2012-2017)
Table China Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Type (2012-2017)
Table China Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type (2012-2017)
Figure China Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type in 2016
Table China Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Applications (2012-2017)
Table China Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application (2012-2017)
Figure China Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application in 2016
Figure Japan Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Japan Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Onychomycosis (Tinea Unguium) Drug Sales Price (USD/MT) Trend (2012-2017)
Table Japan Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Type (2012-2017)
Table Japan Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type in 2016
Table Japan Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Applications (2012-2017)
Table Japan Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application in 2016
Figure South Korea Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure South Korea Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Onychomycosis (Tinea Unguium) Drug Sales Price (USD/MT) Trend (2012-2017)
Table South Korea Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Type (2012-2017)
Table South Korea Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type (2012-2017)
Figure South Korea Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type in 2016
Table South Korea Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Applications (2012-2017)
Table South Korea Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application (2012-2017)
Figure South Korea Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application in 2016
Figure Taiwan Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Taiwan Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Onychomycosis (Tinea Unguium) Drug Sales Price (USD/MT) Trend (2012-2017)
Table Taiwan Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Type (2012-2017)
Table Taiwan Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type in 2016
Table Taiwan Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Applications (2012-2017)
Table Taiwan Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application in 2016
Figure India Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure India Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Onychomycosis (Tinea Unguium) Drug Sales Price (USD/MT) Trend (2012-2017)
Table India Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Type (2012-2017)
Table India Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type (2012-2017)
Figure India Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type in 2016
Table India Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Application (2012-2017)
Table India Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application (2012-2017)
Figure India Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Southeast Asia Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Price (USD/MT) Trend (2012-2017)
Table Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Type (2012-2017)
Table Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Applications (2012-2017)
Table Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application in 2016
Figure Australia Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Australia Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Onychomycosis (Tinea Unguium) Drug Sales Price (USD/MT) Trend (2012-2017)
Table Australia Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Type (2012-2017)
Table Australia Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type (2012-2017)
Figure Australia Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Type in 2016
Table Australia Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) by Applications (2012-2017)
Table Australia Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application (2012-2017)
Figure Australia Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share by Application in 2016
Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table GSK Onychomycosis (Tinea Unguium) Drug Basic Information List
Table GSK Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GSK Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure GSK Onychomycosis (Tinea Unguium) Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure GSK Onychomycosis (Tinea Unguium) Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Novartis Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Novartis Onychomycosis (Tinea Unguium) Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis Onychomycosis (Tinea Unguium) Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Pfizer Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Onychomycosis (Tinea Unguium) Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Onychomycosis (Tinea Unguium) Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Galderma Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Galderma Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Galderma Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Galderma Onychomycosis (Tinea Unguium) Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Galderma Onychomycosis (Tinea Unguium) Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Letai Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Letai Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Letai Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Letai Onychomycosis (Tinea Unguium) Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Letai Onychomycosis (Tinea Unguium) Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Basic Information List
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate (2012-2017)
Figure Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/MT) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Onychomycosis (Tinea Unguium) Drug
Figure Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug
Figure Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
Table Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Manufacturers in 2016
Table Major Buyers of Onychomycosis (Tinea Unguium) Drug
Table Distributors/Traders List
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Price (USD/MT) and Trend Forecast (2017-2022)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume (K MT) Forecast by Region (2017-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Region in 2022
Figure China Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure China Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure South Korea Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Taiwan Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure India Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Onychomycosis (Tinea Unguium) Drug Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Australia Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales (K MT) Forecast by Type (2017-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Price (USD/MT) Forecast by Type (2017-2022)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales (K MT) Forecast by Application (2017-2022)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories